GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

Wuxi Hyatech Co 688510.SS · CNY

Industrials · Shanghai · 🇨🇳 China

Compare

20.03

+1.68%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Wuxi Hyatech Co

Its shares trade on Shanghai under the ticker 688510.SS. It has been listed since 16 December 2020. In the fiscal year to 31 December 2025, it reported revenue of CN¥698.7m and net income of CN¥102.1m. At that date it held total assets of CN¥2.02bn and shareholders' equity of CN¥1.21bn.

Wuxi Hyatech Co Ltd is a CN-based company operating in Aerospace & Defense industry. The company is headquartered in Wuxi, Jiangsu. The company went IPO on 2020-12-16. Wuxi Hyatech Co Ltd is a China-based company mainly engaged in the research and development, manufacture and sales of key components for aero-engines and medical orthopedic implant forgings. The firm's products include high-performance components such as aviation turbofan engine compressor blades, rotating parts and structural parts, as well as medical orthopedic implant forgings. The firm distributes its products in domestic market and to overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Industrials
Industry
Aerospace & Defense
Listed since
16 Dec 2020
Employees
658
Website
hyatech.cn ↗

Leadership

Pay as last reported

  • Mr. Qi YanChairman of the Board, since 2014CN¥600,000
  • Mr. Weiwei WuChief Financial Officer
  • Mr. Hongda ZhuGeneral ManagerCN¥550,000
  • Mr. Li DingDeputy General ManagerCN¥450,000
  • Mr. Hongxiang JingDeputy General ManagerCN¥500,000
  • Mr. Guangyi ZhangDeputy General ManagerCN¥500,000
  • Mr. Xu WangSecretary of the Board, Director, since 2022CN¥337,500
  • Mr. Haining JiaDirector
  • Mr. Shihai RuanDirector
  • Mr. Ran ShaoDirector, since 2017CN¥500,000
  • Ms. Ying WangDirector
  • Mr. Liang WangIndependent DirectorCN¥62,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Operates in the Aerospace & Defense sector with a focus on aero-engine components and medical orthopedic implants.
  • Has a clear product portfolio including aviation turbofan engine components and medical forgings.
  • Maintains both domestic and international market distribution channels.

Weaknesses

  • Limited public information on financial performance and market share.
  • Dependent on a specialized industry with potential regulatory constraints.
  • No mention of R&D investment or innovation metrics in provided data.

Opportunities

  • Growing demand for aerospace components in global markets.
  • Expansion into medical orthopedic implant markets with potential for international growth.
  • Potential for increased market share following IPO in 2020.

Threats

  • Regulatory challenges in aerospace and medical industries.
  • Competition from established players in aerospace and medical sectors.
  • Economic fluctuations affecting defense and medical spending.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.